Skip to main content
PALX logo

PALX · Palomino Laboratories Inc. · Metrics

Track PALX — free
$14.00 At close · Oct 15
Market Cap
$386.91M
Shares
27.64M
Volume · Oct 15 4556 Avg daily vol (3M) 3955

PALX metrics

35 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.00
Market cap
$386.91M

Price action

20 metrics
Price change (1W)
-12.5%
Price change (30D)
-12.5%
Price change (3M)
+90.5%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
43.1
Price vs SMA 50
-7.2%
Price vs SMA 200
—
Avg volume (3M)
3,955
Relative volume
1.2
Average dollar volume
$48,638

Company

3 metrics
Sector
—
Industry
—
Shares outstanding
27.64M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
18.8
reciprocal yield 5.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$4.96M
Net income (TTM)
−$5.18M
Trailing 12 months
Diluted EPS (TTM)
$-0.31
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.43

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
-450.5%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-140.0%
Shares change YoY
+744.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-25.2%
Return on assets
-24.6%
Debt / equity
0.0
Current ratio
53.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
53.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$19.44M
Latest balance sheet
Cash & equivalents
$19.44M
Total assets
$21.04M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$3.44M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$1.53M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
31 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1938569 CUSIP 909233108 Visit website Investor relations